Research Article: Recombinant Human Adenovirus Type (H) Intra-Tumor Therapy in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer: Genomic Profiling Relating to Clinical Efficacy
Introduction:
Patients with persistent, recurrent, or metastatic (P/R/M) cervical carcinoma respond poorly to treatment despite the best available therapeutic regimens, with a -year survival of %. Most of them are heavily pretreated with chemotherapy and/or radiotherapy, and many patients experience complications related to treatment or advanced disease, which exclude them from clinical trial enrollment. Immunotherapy has desirable potency for certain virally associated epithelial malignancies such as cervical , and head and…
Read more